| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5584463 | Experimental and Molecular Pathology | 2017 | 7 Pages |
Abstract
These data suggest a reduced tumor DNA shedding and an increased clearance of the tumor DNA from the circulation in renal cancer patients independently of tumor size, metastases, and necrosis. This implies that highly sensitive detection methods for mutation calling and prior knowledge of the mutation are required for liquid biopsies in ccRCC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Claudia Corrò, Tomas Hejhal, Cédric Poyet, Tullio Sulser, Thomas Hermanns, Thomas Winder, Gerald Prager, Peter J. Wild, Ian Frew, Holger Moch, Markus Rechsteiner,